Provided by Tiger Fintech (Singapore) Pte. Ltd.

Super League Gaming Inc.

0.3717
+0.01072.96%
Post-market: 0.41490.0432+11.62%19:57 EDT
Volume:158.77K
Turnover:58.79K
Market Cap:6.17M
PE:-0.08
High:0.3855
Open:0.3700
Low:0.3610
Close:0.3610
Loading ...

Super League Enterprise files $100M mixed securities shelf

TIPRANKS
·
14 Dec 2024

Super League Enterprise Inc Files for Mixed Shelf of up to $100 Mln – SEC Filing

THOMSON REUTERS
·
14 Dec 2024

American Egg Board Debuts “Tower of Eggs” Activation in Roblox, Featuring Obstacle Gameplay and Recipe Challenges

GlobeNewswire
·
12 Dec 2024

Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus

GlobeNewswire
·
10 Dec 2024

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
10 Dec 2024

Super League Enterprise files to sell 3.03M shares of common stock for holders

TIPRANKS
·
06 Dec 2024

Super League Enterprise Inc Files for Offering of up to 3.03 Mln Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
06 Dec 2024

Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

GlobeNewswire
·
05 Dec 2024

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Zacks Small Cap Research
·
03 Dec 2024

Allogene Therapeutics Loses 23% Year to Date: How to Play the Stock?

Zacks
·
03 Dec 2024

Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus

GlobeNewswire
·
02 Dec 2024

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Motley Fool
·
30 Nov 2024

Press Release: Fate Therapeutics Announces Leadership Transition

Dow Jones
·
30 Nov 2024

BRIEF-Super League Enterprise Issues Unsecured Promissory Note For $1.5 Million

Reuters
·
21 Nov 2024

Super League Enterprise Inc - Issues Unsecured Promissory Note for $1.5 Million

THOMSON REUTERS
·
21 Nov 2024

Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside

Benzinga
·
21 Nov 2024